...
首页> 外文期刊>Journal of Medicinal Chemistry >Structure-Activity Relationship Studies of Substituted 2-(Isoxazol-3-yl)-2-oxo-N '-phenyl-acetohydrazonoyl Cyanide Analogues: Identification of Potent Exchange Proteins Directly Activated by cAMP (EPAC) Antagonists
【24h】

Structure-Activity Relationship Studies of Substituted 2-(Isoxazol-3-yl)-2-oxo-N '-phenyl-acetohydrazonoyl Cyanide Analogues: Identification of Potent Exchange Proteins Directly Activated by cAMP (EPAC) Antagonists

机译:取代的2-(异恶唑-3-基)-2-氧代-N'-苯基-乙酰肼基酰氰类似物的结构-活性关系研究:由cAMP(EPAC)拮抗剂直接激活的强交换蛋白的鉴定

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Exchange proteins directly activated by cAMP (EPAC) as guanine nucleotide exchange factors mediate the effects of the pivotal second messenger cAMP, thereby regulating a wide variety of intracellular physiological and pathophysiological processes. A series of novel 2-(isoxazol-3yl)-2-oxo-N'-phenyl-acetohydrazonoyl cyanide EPAC antagonists was synthesized and evaluated in an effort to optimize properties of the previously identified high-throughput (HTS) hit 1 (ESI-09). Structure activity relationship (SAR) analysis led to the discovery of several more active EPAC antagonists (e.g., 22 (HJC0726), 35 (NY0123), and 47 (NY0173)) with low micromolar inhibitory activity. These inhibitors may serve as valuable pharmacological probes to facilitate our efforts in elucidating the biological functions of EPAC and developing potential novel therapeutics against human diseases. Our SAR ring as well as the 5-position of the results have also revealed that further modification at the 3-, 4-, and 5-positions of the phenyl isoxazole moiety may allow for the development of more potent EPAC antagonists.
机译:cAMP(EPAC)作为鸟嘌呤核苷酸交换因子直接激活的交换蛋白介导关键的第二信使cAMP的作用,从而调节多种细胞内生理和病理生理过程。合成并评估了一系列新颖的2-(异恶唑-3基)-2-氧代-N'-苯基-乙酰肼基酰氰EPAC拮抗剂,以优化先前确定的高通量(HTS)命中1(ESI- 09)。结构活性关系(SAR)分析导致发现了几种具有较低微摩尔抑制活性的活性更高的EPAC拮抗剂(例如22(HJC0726),35(NY0123)和47(NY0173))。这些抑制剂可以作为有价值的药理探针,以帮助我们阐明EPAC的生物学功能并开发针对人类疾病的潜在新疗法。我们的SAR环以及结果的5位也表明,在苯基异恶唑部分的3位,4位和5位的进一步修饰可能允许开发更有效的EPAC拮抗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号